These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7586289)

  • 41. Imaging metabolism and biochemistry--a new look at the heart.
    Schelbert HR; Phelps ME; Shine KI
    Am Heart J; 1983 Mar; 105(3):522-6. PubMed ID: 6600873
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.
    Berry JJ; Baker JA; Pieper KS; Hanson MW; Hoffman JM; Coleman RE
    J Nucl Med; 1991 Aug; 32(8):1518-25. PubMed ID: 1869972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FDG uptake within regionally stunned myocardium.
    McFalls EO; Ward H
    Am J Card Imaging; 1995 Oct; 9(4):269-74. PubMed ID: 8680144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Viable myocardium identified by reinjection thallium-201 imaging: comparison with regional wall motion and metabolic activity on FDG-PET.
    Tamaki N; Ohtani H; Yonekura Y; Shindo M; Nohara R; Kambara H; Kawai C; Hirata K; Ban T; Konishi J
    J Cardiol; 1992; 22(2-3):283-93. PubMed ID: 1339787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Positron emission tomography of the heart.
    Bergmann SR; Fox KA; Geltman EM; Sobel BE
    Prog Cardiovasc Dis; 1985; 28(3):165-94. PubMed ID: 3877316
    [No Abstract]   [Full Text] [Related]  

  • 46. [Myocardial viability evaluation by nuclear cardiology].
    Bunko H; Hisada K
    Kokyu To Junkan; 1990 Mar; 38(3):201-8. PubMed ID: 2330451
    [No Abstract]   [Full Text] [Related]  

  • 47. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
    Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of blood flow on the positron-emission tomographic determination of substrate transport rates.
    Holden JE
    Circulation; 1985 Nov; 72(5 Pt 2):IV72-6. PubMed ID: 3876895
    [No Abstract]   [Full Text] [Related]  

  • 49. Myocardial blood flow and FDG retention in acutely stunned porcine myocardium.
    McFalls EO; Ward H; Fashingbauer P; Gimmestad G; Palmer B
    J Nucl Med; 1995 Apr; 36(4):637-43. PubMed ID: 7699459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 51. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 52. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography.
    Hicks RJ; Herman WH; Kalff V; Molina E; Wolfe ER; Hutchins G; Schwaiger M
    J Am Coll Cardiol; 1991 Jul; 18(1):101-11. PubMed ID: 2050912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. F-18 FDG uptake in transplanted heart.
    Taegtmeyer H; Doenst T
    J Am Coll Cardiol; 1998 May; 31(6):1441-2. PubMed ID: 9581748
    [No Abstract]   [Full Text] [Related]  

  • 55. Septal metabolic mismatch in LBBB.
    Burns RJ
    J Nucl Med; 1996 Nov; 37(11):1918-9. PubMed ID: 8917212
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
    Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
    Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucose metabolism in relation to perfusion in patients with ischaemic heart disease.
    Takahashi N; Tamaki N; Kawamoto M; Yonekura Y; Magata Y; Nohara R; Sasayama S; Konishi J; Yamamoto K; Ishii Y
    Eur J Nucl Med; 1994 Apr; 21(4):292-6. PubMed ID: 8005152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Temporal analysis of myocardial glucose metabolism by 2-[18F]fluoro-2-deoxy-D-glucose.
    Nguyêñ VT; Mossberg KA; Tewson TJ; Wong WH; Rowe RW; Coleman GM; Taegtmeyer H
    Am J Physiol; 1990 Oct; 259(4 Pt 2):H1022-31. PubMed ID: 2221110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The FDG model and its application in clinical PET studies.
    Wienhard K
    J Neural Transm Suppl; 1992; 37():39-52. PubMed ID: 1402851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.